ATE184200T1 - Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe - Google Patents

Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Info

Publication number
ATE184200T1
ATE184200T1 AT93914851T AT93914851T ATE184200T1 AT E184200 T1 ATE184200 T1 AT E184200T1 AT 93914851 T AT93914851 T AT 93914851T AT 93914851 T AT93914851 T AT 93914851T AT E184200 T1 ATE184200 T1 AT E184200T1
Authority
AT
Austria
Prior art keywords
pct
treatment
brorelain
infectious diarrhea
enzymes especially
Prior art date
Application number
AT93914851T
Other languages
English (en)
Inventor
Tracey Leahanne Mynott
Original Assignee
Cortecs Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213862A external-priority patent/GB9213862D0/en
Priority claimed from GB939308164A external-priority patent/GB9308164D0/en
Priority claimed from GB939313189A external-priority patent/GB9313189D0/en
Application filed by Cortecs Uk Ltd filed Critical Cortecs Uk Ltd
Application granted granted Critical
Publication of ATE184200T1 publication Critical patent/ATE184200T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT93914851T 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe ATE184200T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929213862A GB9213862D0 (en) 1992-06-30 1992-06-30 Medical use of enzymes
GB939308164A GB9308164D0 (en) 1993-04-20 1993-04-20 Medical use of enzymes
GB939313189A GB9313189D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes

Publications (1)

Publication Number Publication Date
ATE184200T1 true ATE184200T1 (de) 1999-09-15

Family

ID=27266268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914851T ATE184200T1 (de) 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Country Status (13)

Country Link
US (1) US5928640A (de)
EP (1) EP0671943B1 (de)
JP (1) JPH08503691A (de)
AT (1) ATE184200T1 (de)
AU (1) AU672986B2 (de)
CA (1) CA2137674A1 (de)
DE (1) DE69326351T2 (de)
DK (1) DK0671943T3 (de)
ES (1) ES2138625T3 (de)
GR (1) GR3031961T3 (de)
NZ (1) NZ253748A (de)
SG (1) SG42846A1 (de)
WO (1) WO1994000147A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
ATE382084T1 (de) * 1997-02-25 2008-01-15 Sarantis Pty Ltd Bromelinbestandteil
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
ATE222121T1 (de) * 1998-07-15 2002-08-15 Ursapharm Arzneimittel Gmbh Verwendung von bromelainproteasen zur hemmung der blutgerinnung
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
US20040166198A1 (en) * 2001-04-25 2004-08-26 Kiers Jeroen Lucas Process for the manufacture of a fermented health-promoting product
SI1809320T1 (sl) * 2004-10-14 2010-11-30 Cystic Fibrosis Foundation Therapeutics Inc Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US12149618B2 (en) 2005-01-27 2024-11-19 The Chamberlain Group Llc Method and apparatus to facilitate transmission of an encrypted rolling code
US8422667B2 (en) 2005-01-27 2013-04-16 The Chamberlain Group, Inc. Method and apparatus to facilitate transmission of an encrypted rolling code
US9148409B2 (en) 2005-06-30 2015-09-29 The Chamberlain Group, Inc. Method and apparatus to facilitate message transmission and reception using different transmission characteristics
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
CN108472341A (zh) * 2015-08-20 2018-08-31 安纳塔拉生命科学有限公司 具有抗炎活性的酶级分
RU2732224C9 (ru) 2016-01-31 2021-06-18 Медивунд Лтд. Раноочищающая композиция для лечения ран
US10652743B2 (en) 2017-12-21 2020-05-12 The Chamberlain Group, Inc. Security system for a moveable barrier operator
US11074773B1 (en) 2018-06-27 2021-07-27 The Chamberlain Group, Inc. Network-based control of movable barrier operators for autonomous vehicles
CA3107457A1 (en) 2018-08-01 2020-02-06 The Chamberlain Group, Inc. Movable barrier operator and transmitter pairing over a network
US10997810B2 (en) 2019-05-16 2021-05-04 The Chamberlain Group, Inc. In-vehicle transmitter training

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617417A1 (de) * 1966-12-08 1971-03-25 Ciba Geigy Pharmazeutisches Praeparat
JPS5299207A (en) * 1976-02-16 1977-08-19 Kaken Pharmaceut Co Ltd Remedy for cattle diarrhea
FR2414554A1 (fr) * 1978-01-13 1979-08-10 Steeg Lottie Nouveau milieu de culture bacterienne et ses applications comme additif alimentaire et medicament pour animaux
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
WO1993001800A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids

Also Published As

Publication number Publication date
GR3031961T3 (en) 2000-03-31
DE69326351D1 (de) 1999-10-14
DK0671943T3 (da) 2000-03-27
ES2138625T3 (es) 2000-01-16
HK1004193A1 (en) 1998-11-20
EP0671943A1 (de) 1995-09-20
EP0671943B1 (de) 1999-09-08
AU672986B2 (en) 1996-10-24
CA2137674A1 (en) 1994-01-06
WO1994000147A1 (en) 1994-01-06
NZ253748A (en) 1997-06-24
US5928640A (en) 1999-07-27
JPH08503691A (ja) 1996-04-23
SG42846A1 (en) 1997-10-17
DE69326351T2 (de) 2000-05-18
AU4507493A (en) 1994-01-24

Similar Documents

Publication Publication Date Title
DE69326351D1 (de) Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
DE59509646D1 (de) Mikroorganismen enthaltende granulate
DK0699104T3 (da) Fremgangsmåde til underkritisk tørring af aerogeler
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
DE69508192D1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
FI946185A0 (fi) Ligniinin polymerointi alkalisessa pH:ssa
DE69418035D1 (de) Hiv-proteaseinhibitoren
ATE226058T1 (de) Verwendung von lysin zur behandlung des haarausfalls
FI961054A0 (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
AU4720093A (en) Inhibitor resistant serine proteases
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DK164176C (da) Bacillus subtilis dsm 2704 og anvendelse heraf i en fremgangsmaade til fremstilling af alfa-amylase
DE69400702D1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9304399D0 (en) Novel process
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
PL309339A1 (en) Novel triazoquinazolines, methods of obtaining them and their application
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee